<DOC>
	<DOCNO>NCT01286376</DOCNO>
	<brief_summary>Determine effectiveness symbiotic LACTOFOS contain FOS probiotic placebo patient diagnosis constipation , compare average number weekly evacuation 2 ( two ) group 30 day .</brief_summary>
	<brief_title>Evaluating Effectiveness LACTOFOS Constipated Patients</brief_title>
	<detailed_description>A prospective , randomize , double blind , parallel group . Consist period 30 day treatment placebo LACTOFOS.Will study 120 patient female diagnosis constipation accord Rome III criterion least 3 ( three ) month . The experimental group ( N = 60 ) receive LACTOFOS 12g/day two dos 6 g. The control group ( N = 60 ) receive placebo ( maltodextrin ) 12g/day two shot 6 g. Subsequently , patient classify accord study AGACHAN , determine score base main complaint patient . The symptom include evaluation total score stool frequency , difficulty / straining , pain defecation , feel incomplete evacuation , abdominal pain , time take initiate evacuation , type assistance evacuation , fail attempt / day duration constipation . The intensity symptom vary within range 0 4 , exception item type assistance evacuation , range 0 2 . Constipation classify mild total sum value ( score ) vary 00 10 , moderate sum value obtain vary 11 20 severe final sum range 21 30 .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>1 . Females age 1875 year 2 . A diagnosis constipation define Rome III criteria 3 . Ability good communication investigator agree request entire study 4 . Patients must sign formal consent participate 1 . Constipation drug source 2 . History evidence organic disease gastrointestinal tract tumor , inflammatory bowel disease , etc.. proven radiological endoscopic examination bowel ( five year onset symptom ) . If investigator doubt request necessary procedure , sigmoidoscopy , colonoscopy edema bariatric exclude organic disease 3 . History laxative use opinion investigator consistent severe laxative dependence 4 . Current History recent ( 12 month ) significant abuse alcohol drug 5 . History malignancy 5 ( five ) previous year ( except basal cell carcinoma treat well cervical carcinoma situ ) 6 . Known history cardiovascular control inappropriate / significant respiratory , renal , hepatic , gastrointestinal , hematological , neurological , psychiatric illness compromise ability patient participate full study 7 . Use investigational drug previous month intentional use drug study 8 . Intention regular use medication affect intestinal motility / perceive 9 . Lactose malabsorption treatable . If clinical suspicion lactose intolerance , procedure proper diagnosis make establish exclude diagnosis . If malabsorption diagnose , patient receive appropriate condition treatment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Symbiotics</keyword>
	<keyword>Fiber</keyword>
	<keyword>Constipation</keyword>
</DOC>